Published in
Regular and Young Investigator Award Abstracts, 2023
DOI: 10.1136/jitc-2023-sitc2023.0694
Links
Tools
694 A randomized phase II clinical trial of SBRT and pembrolizumab with or without intratumoral avelumab/ipilimumab plus CD1c(BDCA-1)<sup>+</sup>/CD141(BDCA-3)<sup>+</sup>myeloid dendritic cells in solid tumors
Proceedings article published in 2023 by
Manon Vounckx,
Jens Tijtgat,
Iris Dirven,
Frederik Vandenbroucke,
Steven Raemaeckers,
Bart Ilsen,
Selma Ben Mustapha,
Jens Van Loon,
Latoya Stevens,
Xenia Geeraerts 
,
Ivan Van Riet,
Ines Dufait,
Sandra Tuyaerts,
Lore Decoster,
Mark De Ridder
and other authors.
,
Ivan Van Riet,
Ines Dufait,
Sandra Tuyaerts,
Lore Decoster,
Mark De Ridder
and other authors.
